Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Healthcare Tourism

 

Investors discuss opportunities in Nigeria’s private healthcare sector

A panel of Nigeria's healthcare operators, private equity investors and finance institutions including the IFC discussed opportunities for financing the sector in a recent panel discussion. HBI asked one of them whether recent entries into the diagnostics space from foreign entities are a benefit or are just helping to cream off the top-tier of the market.

COVID-19 and Emerging Market healthcare

We talk to two of the world's largest investors in emerging market health care about Covid's likely impact. Despite so far much lower death rates, the initial effect on health care operators has been worse than in Europe. Covid is set to destroy several motors for growth such as healthcare tourism and the deployment of […]

Covid: The double whammy – who will be left standing?

In a recent paper on the medtech outlook for Europe, UBS, looked at how Singapore and Toronto bounced back from pandemics. Pent up demand simply led to double growth rates the year after. But Covid is two things: a pandemic coupled to a steep recession, almost certainly worse than 2008. We look at what this means for a sector where private equity has often geared up to the hilt.

COVID-19: Threats and opportunities

Covid-19 is going to have a huge impact on for-profit healthcare services. In the first of a two-part report, we look at what that will be at a sector and country level. Digital health looks like being a winner, Ping An claims online consultations are up tenfold, with the spectre of a crash in elective procedures hanging over for-profit hospitals and specialist outpatient chains. We also look at the likely impact on M&A.  The second part of this report, focussing on the care sector, will be published next week.

NMC identifies $335m side deals and sacks CEO

In an announcement put out after trading, the independent review board appointed by NMC has identified side deals on procurement worth US$335m with the founders for which NMC is liable and that were made without board approval. It has also removed Mr Prasanth Manghat from his position of Director and CEO of the Company with immediate effect.

Interview: Rajesh Rao, CEO, IndusHealth

US healthcare is so prohibitively expensive that not only are employers paying for employees to have surgery abroad and covering all costs - they are paying the employees thousands of dollars as an incentive to go too! HBI speaks to the CEO of a company trying to grow the US employer-funded medical travel segment, who sees opportunities for providers in Europe and Latin America.

Dispatches from Arab Health

Arab Health never seems to get any smaller. HBI travelled to Dubai and spoke to some of the 84,500 attendees and 4,150 exhibiting companies. But, strip out the hoop-la, and what is really going on at ground level? Here are our main takeaways from the four-day long event:

Find Us